Zacks Research Has Bearish Estimate for Teleflex Q4 Earnings

Teleflex Incorporated (NYSE:TFX) – Research analysts at Zacks Research dropped their Q4 2024 EPS estimates for shares of Teleflex in a research report issued on Wednesday, January 8th. Zacks Research analyst R. Department now expects that the medical technology company will post earnings per share of $3.83 for the quarter, down from their prior forecast of $3.85. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s Q2 2025 earnings at $3.71 EPS, Q3 2025 earnings at $3.75 EPS, Q4 2025 earnings at $4.18 EPS, FY2025 earnings at $15.16 EPS, Q4 2026 earnings at $4.16 EPS and FY2026 earnings at $16.59 EPS.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $764.40 million for the quarter, compared to analyst estimates of $768.68 million. During the same period last year, the firm posted $3.64 EPS. Teleflex’s quarterly revenue was up 2.4% on a year-over-year basis.

Several other equities research analysts have also commented on the stock. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Truist Financial decreased their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Mizuho decreased their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Finally, Royal Bank of Canada decreased their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Teleflex Stock Performance

NYSE:TFX opened at $174.75 on Friday. The firm’s fifty day moving average price is $186.33 and its 200 day moving average price is $216.34. Teleflex has a 1-year low of $171.69 and a 1-year high of $256.85. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The firm has a market cap of $8.12 billion, a price-to-earnings ratio of 34.74, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16.

Institutional Investors Weigh In On Teleflex

Institutional investors and hedge funds have recently made changes to their positions in the business. Cromwell Holdings LLC raised its stake in Teleflex by 59.0% in the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after purchasing an additional 49 shares during the last quarter. Avior Wealth Management LLC raised its stake in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after purchasing an additional 101 shares during the last quarter. Ashton Thomas Securities LLC acquired a new position in Teleflex in the 3rd quarter valued at about $40,000. True Wealth Design LLC raised its stake in Teleflex by 16,600.0% in the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after purchasing an additional 166 shares during the last quarter. Finally, Canada Pension Plan Investment Board acquired a new position in Teleflex in the 2nd quarter valued at about $42,000. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Friday, November 15th were given a $0.34 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.78%. Teleflex’s dividend payout ratio is presently 27.04%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.